Addiction response community convenes April 6-9 in Nashville to build on progress, address persistent overdose risk, and focus on outcomes in a changing funding environment.

Across the addiction and recovery field, funding uncertainty is shaping day-to-day decisions.

At the same time, the opioid and addiction crisis remains a critical public health emergency that demands focus and follow-through. Although overall overdose death rates are decreasing, the CDC estimated that 73,000 Americans died of overdoses in the 12-month period ending August 2025.

This is why the 2026 Rx and Illicit Drug Summit, April 6-9 in Nashville, matters now. Rx Summit is designed to help professionals stay grounded in data, share what works, and focus on outcomes in an unpredictable environment.

Funding Realities
 

The current funding environment is volatile, but it is not uniformly collapsing.

Recent reporting described abrupt changes to certain SAMHSA grant awards followed by reinstatements, creating operational disruption for multiple stakeholders. At the same time, State Opioid Response and Tribal Opioid Response FY25 continuation awards totaling more than $1.5 billion were announced to support prevention, medication for opioid use disorder, recovery supports, and overdose reversal.

Opioid settlement funds continue to function as a separate, multi-year funding stream for state and local response, though allocation and oversight vary widely. The White House has also signaled renewed attention to addiction and recovery through recent initiatives and executive actions, reinforcing that this work remains a national priority.

Signals to Watch and Noise to Avoid
 

Signals that matter

• CDC overdose trend releases that show directional change over time
• Federal budget and agency structure decisions affecting behavioral health capacity
• Grant policy shifts that affect eligibility, renewals, or cash flow timing
• State and local opioid settlement spending decisions and outcome expectations
• Employer and payer behavior related to benefits, utilization, and workforce wellbeing

Noise to avoid

• One headline = the system is ending
• One grant = the only plan
• One model = the only answer
   

Why Rx Summit Is Built for This Moment
 

Rx Summit is grounded in multidisciplinary collaboration, actionable strategies, and real results. Session selection emphasizes what is working, what evidence shows these approaches are working, and how they can be replicated.

The program spans six key tracks: clinical, public safety, prevention, recovery support, advocacy, and illicit drugs. The Rx Summit brings together leaders across the full continuum and routinely features federal and state officials, along with nationally recognized experts, to support informed, policy-aware discussions.

Who Benefits and How Attendance Delivers ROI
 

Program leaders gain clarity on how peers are aligning funding, outcomes, and accountability. Clinical and treatment teams access CME and CE eligible education and implementation-ready models they can apply immediately.

For teams navigating budget or travel constraints, Rx Summit offers In-Person or On-Demand participation options. A conference approval letter template is also available to support employer justification, budget requests, and travel alternatives.

Progress requires steady leadership and shared learning. I invite you to join me this spring in Nashville to strengthen your work, connect with peers, and keep moving this field forward together.

Event Details
 

• Name: Rx and Illicit Drug Summit
• Dates and Location: April 6-9, Nashville, Tennessee
• Website
• Registration (In-Person or On-Demand)
• Conference Approval Letter Template
• Follow us on LinkedIn